GlassScriptPhysician profile
Sarah A Mess
NPI 1740281047
$177,800.86
in general payments reported to CMS, 2019-2025
12 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,874 · 2020: $2,763 · 2021: $13K · 2022: $63K · 2023: $33K · 2024: $32K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77K · Food and Beverage: $4,611 · Travel and Lodging: $4,445 · Consulting Fee: $3,738 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $76,620.62 |
| Food and Beverage | $4,611.37 |
| Travel and Lodging | $4,445.20 |
| Consulting Fee | $3,737.50 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $88,110.49 | 2019-2023 | |
| Abbvie INC. | $83,094.69 | 2023-2025 | |
| Motiva USA, LLC | $3,647.44 | 2025 | |
| Davol INC. | $1,736.91 | 2022-2025 | |
| Galderma Laboratories, L.P. | $440.77 | 2019-2025 | Dysport |
| Sientra, INC. | $430.03 | 2020-2022 | |
| Biom'Up Sa | $122.87 | 2019 | |
| Mentor Worldwide LLC | $70.58 | 2021 | |
| Smith+Nephew, INC. | $57.44 | 2019-2023 | Pico, Pico 7, Acticoat 4" X 4" |
| Pacira Pharmaceuticals Incorporated | $45.85 | 2023-2025 | Exparel |
| Integra Lifesciences Corporation | $32.10 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Apyx Medical Corporation | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Mess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.